GlaxoSmithKline to cut 650 US jobs, reinvest in R & D


The News & Observer reports the United Kingdom-based company notified the North Carolina Department of Commerce on Wednesday that it will cut 100 jobs at its Research Triangle Park office, and 450 field sales jobs across the country. GlaxoSmithKline is also cutting 100 positions at its Philadelphia office.



from Biotech News